Form MGT-7 - Annual Return (other than OPCs and Small Companies)

Sep 14, 2026

Annual Return Form MGT-7 consolidates company registration and statutory disclosures under the Companies Act, 2013 and relevant rules. It captures key details such as CIN/GLN, PAN, registered office, email, telephone, website, incorporation date, company type and category, share capital and whether shares are listed on recognized stock exchanges, along with registrar and transfer agent information. The form also covers financial year dates, AGM status and due dates, principal business activities, and particulars of holding, subsidiary, and associate companies including shareholding percentages, followed by share capital details.

LanguageEnglish

CategoryExam

FormatPDF

Pages36

Reading Time1 h 31 min

AccessFree to download

Annual Return (other than OPCs and Small Companies)

Registration and Other Details

Principal Business Activities of the Company

Particulars of Holding, Subsidiary and Associate Companies

Share Capital, Debentures and Other Securities of the Company

DRAFT | FORM NO. MGT-7
[Pursuant to sub-Section(1) of section 92 of the Companies Act, 2013 and sub-rule (1) of rule 11of the Companies (Management and Administration) Rules, 2014] | Annual Return (other than OPCs and Small Companies) | | --- | --- | Form language English Hindi Refer the instruction kit for filing the form. I. REGISTRATION AND OTHER DETAILS (i) * Corporate Identification Number (CIN) of the company Global Location Number (GLN) of the company * Permanent Account Number (PAN) of the company (ii) (a) Name of the company (b) Registered office address Pre-fill | B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI NA MUMBAI
Maharashtra 400026 India |
| | --- | --- | (c) *e-mail ID of the company (d) *Telephone number with STD code (e) Website (iii) Date of Incorporation (iv) | Type of the Company | Category of the Company | Sub-category of the Company | | --- | --- | --- | | Public Company | Company limited by shares | Indian Non-Government company | (v) Whether company is having share capital (vi) *Whether shares listed on recognized Stock Exchange(s) Yes Yes No No (a) Details of stock exchanges where shares are listed | S. No. | Stock Exchange Name | Code | | --- | --- | --- | | 1 | BSE Limited | 1 | | 2 | National Stock Exchange of India Limited | 1,024 | (b) CIN of the Registrar and Transfer Agent Name of the Registrar and Transfer Agent L72400TG2017PLC117649 Pre-fill KFIN TECHNOLOGIES LIMITED Registered office address of the Registrar and Transfer Agents Selenium, Tower B, Plot No-31 & 32, Financial District, Nanakramguda, Serili ngampally NA (vii) * Financial year From date 01/04/2023 (DD/MM/YYYY) To date 31/03/2024 (DD/MM/YYYY) (viii) *Whether Annual general meeting (AGM) held Yes No (a) If yes, date of AGM (b) Due date of AGM 30/09/2024 (c) Whether any extension for AGM granted Yes No II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY *Number of business activities 1 | S.No | Main Activity group code | Description of Main Activity group | Business Activity Code | Description of Business Activity | % of turnover of the company | | --- | --- | --- | --- | --- | --- | | 1 | C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and | 100 | b t i l d t III. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES (INCLUDING JOINT VENTURES) *No. of Companies for which information is to be given 43 Pre-fill All | S.No | Name of the company | CIN / FCRN | Holding/ Subsidiary/Associate/ Joint Venture | % of shares held | | --- | --- | --- | --- | --- | | 1 | GLENMARK HEALTHCARE LIMI
| TU21001MH2023PLC402796 | Subsidiary | 100 | | 2 | Ichnos Sciences Inc., USA | | Subsidiary | 100 | | 3 | Glenmark Holding S.A. | | Subsidiary | 100 | | --- | --- | --- | --- | --- | | 4 | Glenmark Pharmaceuticals Eur
| | Subsidiary | 100 | | 5 | Glenmark Pharmaceuticals S. R
| | Subsidiary | 100 | | 6 | Glenmark Pharmaceuticals SK,
| | Subsidiary | 100 | | 7 | Ichnos Sciences SA (Formerly k
| | Subsidiary | 100 | | 8 | Glenmark Pharmaceuticals SP z
| | Subsidiary | 100 | | 9 | Glenmark Pharmaceuticals Inc
| | Subsidiary | 100 | | 10 | Glenmark Therapeutics Inc. | | Subsidiary | 100 | | 11 | Glenmark Farmaceutica Ltda | | Subsidiary | 100 | | 12 | Glenmark Generics S.A | | Subsidiary | 100 | | 13 | Glenmark Pharmaceuticals Me
| | Subsidiary | 100 | | 14 | Glenmark Pharmaceuticals Per
| | Subsidiary | 100 | | 15 | Glenmark Pharmaceuticals Col
| | Subsidiary | 100 | | 16 | Glenmark Uruguay S.A. | | Subsidiary | 100 | | 17 | Glenmark Pharmaceuticals Ven
| | Subsidiary | 100 | | 18 | Glenmark Dominicana SRL | | Subsidiary | 100 | | 19 | Glenmark Pharmaceuticals Egy
| | Subsidiary | 100 | | 20 | Glenmark Pharmaceuticals FZE
| | Subsidiary | 100 | | 21 | Glenmark Impex L.L.C | | Subsidiary | 100 | | 22 | Glenmark Philippines Inc | |

FAQs

What information does Form MGT-7 collect for a company’s annual return?

It collects registration details, company type/category, share capital and listing status, AGM information, principal business activities, and particulars of holding/subsidiary/associate companies with shareholding percentages, along with share capital figures.

Which statutory references are cited for filing Form MGT-7?

The form references provisions under the Companies Act, 2013, specifically section 92(1) and the related rules for annual return filing.

How are principal business activities reported in Form MGT-7?

They are reported by the number of business activities, main activity group and description, business activity code and description, and the percentage of turnover.

Sep 14, 2026

Uploaded by Maya Linwood